Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
, training, and advising researchers. The work will involve diverse and challenging samples from both mouse models and human tissues. Main responsibilities Develop and implement high-dimensional spectral flow
-
Research (IRC) is hosted at Ghent University and Vrije Universiteit Brussel and currently includes 20+ Principal Investigators and 450 scientists from around the world. IRC investigates the molecular and
-
on specific tasks within the ERC project, such as qualitative data collection, analysis, and integration of findings. You will support the Principal Investigator (PI) and actively participate in
-
and an overview of your study results a motivation letter (max. 2 pages) copy of your diploma (if already in your possession) summary (1-pager) of your master dissertation or of a recent academic
-
contribute to teaching activities, particularly within the Master's course Robotic Manipulation in Space Drive high-impact research dissemination by leading first-author submissions to top-tier (top 10
-
limited number of teaching and research support tasks. Profile You hold a Master's degree in Neuroscience, Biotechnology, Biomedical Sciences, Bio(medical) Engineering, Pharmacology, (Medical) Physics
-
, a transcript of records of the bachelor and master curriculum, a copy of degree projects and any previous publications, a proof of English language skills, two recommendation letters (or the names and
-
their master's degree. Important: the candidate does not need to register as a PhD student yet. We only need confirmation that the candidate meets all the conditions. As soon as the project is ready to be
-
: Principal investigators: Postdoctoral researchers: Additional info: In addition to this position at the VUB, we are also looking for a PhD candidate at UCLouvain; you can consult the vacanc here . If you are
-
. Bert Devriendt focuses on gut immunology and host-pathogen interactions at the intestinal surface. Our main interest is in pathogenic E. coli and the development of novel therapies to control